EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 52013XC1129(07)
Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 to 31 October 2013 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 to 31 October 2013 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 to 31 October 2013 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
OJ C 350, 29.11.2013, p. 30–75
(BG, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
OJ C 350, 29.11.2013, p. 30–62
(ES)
29.11.2013 |
EN |
Official Journal of the European Union |
C 350/30 |
Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 to 31 October 2013
(Decisions taken pursuant to Article 34 of Directive 2001/83/EC (1) or Article 38 of Directive 2001/82/EC (2) )
2013/C 350/03
— Issuing, maintenance or modification of a national marketing authorization
Date of the decision |
Name(s) of the medicinal product |
Holder(s) of the marketing authorization |
Member State concerned |
Date of notification |
2.10.2013 |
Suifertil 4 mg/ml |
See Annex I |
See Annex I |
3.10.2013 |
9.10.2013 |
Methylphenidate Hexal |
See Annex II |
See Annex II |
11.10.2013 |
9.10.2013 |
Methylphenidate Sandoz |
See Annex III |
See Annex III |
10.10.2013 |
18.10.2013 |
Dexadreson 2 mg/ml |
See Annex IV |
See Annex IV |
21.10.2013 |
18.10.2013 |
Micotil 300 |
See Annex V |
See Annex V |
21.10.2013 |
31.10.2013 |
Sandimmun |
See Annex VI |
See Annex VI |
4.11.2013 |
31.10.2013 |
Sandimmun Neoral |
See Annex VII |
See Annex VII |
4.11.2013 |
— Suspension of a national marketing authorization
Date of the decision |
Name(s) of the medicinal product |
Holder(s) of the marketing authorization |
Member State concerned |
Date of notification |
11.10.2013 |
Ketoconazole |
See Annex VIII |
See Annex VIII |
14.10.2013 |
(1) OJ L 311, 28.11.2001, p. 67.
(2) OJ L 311, 28.11.2001, p. 1.
ANNEX I
LIST OF THE NAME, PHARMACEUTICAL FORM, STRENGTH OF THE VETERINARY MEDICINAL PRODUCT, ANIMAL SPECIES, ROUTE OF ADMINISTRATION, APPLICANT IN THE MEMBER STATES
Member State EU/EEA |
Applicant |
Name |
INN |
Strength |
Pharmaceutical form |
Animal species |
Route of administration |
||||
Austria |
|
Suifertil 4 mg/ml Lösung zum Eingeben für Schweine |
Altrenogest |
4 mg/ml |
Oral solution |
Pigs (sexually mature gilts) |
For oral use as a top-dressing |
||||
France |
|
Synchroplan 4 mg/ml solution buvable porcins |
Altrenogest |
4 mg/ml |
Oral solution |
Pigs (sexually mature gilts) |
For oral use as a top-dressing |
||||
Germany |
|
Suifertil 4 mg/ml Oral Solution for Pigs |
Altrenogest |
4 mg/ml |
Oral solution |
Pigs (sexually mature gilts) |
For oral use as a top-dressing |
||||
Hungary |
|
Suifertil 4 mg/ml belsőleges oldat sertések részére A.U.V. |
Altrenogest |
4 mg/ml |
Oral solution |
Pigs (sexually mature gilts) |
For oral use as a top-dressing |
||||
The Netherlands |
|
Suifertil 4 mg/ml orale oplossing voor varkens |
Altrenogest |
4 mg/ml |
Oral solution |
Pigs (sexually mature gilts) |
For oral use as a top-dressing |
||||
Poland |
|
Suifertil 4 mg/ml Oral Solution for Pigs |
Altrenogest |
4 mg/ml |
Oral solution |
Pigs (sexually mature gilts) |
For oral use as a top-dressing |
||||
Romania |
|
Suifertil 4 mg/ml Oral Solution for Pigs |
Altrenogest |
4 mg/ml |
Oral solution |
Pigs (sexually mature gilts) |
For oral use as a top-dressing |
||||
Spain |
|
Suifertil 4 mg/ml solución oral para porcino |
Altrenogest |
4 mg/ml |
Oral solution |
Pigs (sexually mature gilts) |
For oral use as a top-dressing |
||||
United Kingdom |
|
Suifertil 4 mg/ml Oral Solution for Pigs |
Altrenogest |
4 mg/ml |
Oral solution |
Pigs (sexually mature gilts) |
For oral use as a top-dressing |
ANNEX II
LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTES OF ADMINISTRATION, APPLICANTS / MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
Member State EU/EEA |
Marketing authorisation holder company name, address |
Applicant company name, address |
(Invented) Name |
Strength |
Pharmaceutical form |
Route of administration |
||||
Denmark |
|
|
Methylphenidate ‘Hexal’ |
18 mg |
Prolonged-release tablet |
Oral use |
||||
Denmark |
|
|
Methylphenidate ‘Hexal’ |
36 mg |
Prolonged-release tablet |
Oral use |
||||
Denmark |
|
|
Methylphenidate ‘Hexal’ |
54 mg |
Prolonged-release tablet |
Oral use |
||||
Germany |
|
|
Methylphenidathydrochlorid HEXAL 18 mg Retardtabletten |
18 mg |
Prolonged-release tablet |
Oral use |
||||
Germany |
|
|
Methylphenidathydrochlorid HEXAL 36 mg Retardtabletten |
36 mg |
Prolonged-release tablet |
Oral use |
||||
Germany |
|
|
Methylphenidathydrochlorid HEXAL 54 mg Retardtabletten |
54 mg |
Prolonged-release tablet |
Oral use |
||||
Ireland |
|
|
Metidate XL 54 mg Prolonged-Release Tablets |
54 mg |
Prolonged-release tablet |
Oral use |
||||
Ireland |
|
|
Metidate XL 18 mg Prolonged-Release Tablets |
18 mg |
Prolonged-release tablet |
Oral use |
||||
Ireland |
|
|
Metidate XL 36 mg Prolonged-Release Tablets |
36 mg |
Prolonged-release tablet |
Oral use |
ANNEX III
LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTES OF ADMINISTRATION, APPLICANTS / MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
Member State EU/EEA |
Marketing authorisation holder company name, address |
Applicant company name, address |
(Invented) Name |
Strength |
Pharmaceutical form |
Route of administration |
|||||
Belgium |
|
|
Methylfenidaat Sandoz 18 mg tabletten met verlengde afgifte |
18 mg |
Prolonged-release tablet |
Oral use |
|||||
Belgium |
|
|
Methylfenidaat Sandoz 36 mg tabletten met verlengde afgifte |
36 mg |
Prolonged-release tablet |
Oral use |
|||||
Belgium |
|
|
Methylfenidaat Sandoz 54 mg tabletten met verlengde afgifte |
54 mg |
Prolonged-release tablet |
Oral use |
|||||
Cyprus |
|
|
Methylphenidate Sandoz |
18 mg |
Prolonged-release tablet |
Oral use |
|||||
Cyprus |
|
|
Methylphenidate Sandoz |
36 mg |
Prolonged-release tablet |
Oral use |
|||||
Cyprus |
|
|
Methylphenidate Sandoz |
54 mg |
Prolonged-release tablet |
Oral use |
|||||
Denmark |
|
|
Methylphenidate ‘Sandoz’ |
18 mg |
Prolonged-release tablet |
Oral use |
|||||
Denmark |
|
|
Methylphenidate ‘Sandoz’ |
36 mg |
Prolonged-release tablet |
Oral use |
|||||
Denmark |
|
|
Methylphenidate ‘Sandoz’ |
54 mg |
Prolonged-release tablet |
Oral use |
|||||
Finland |
|
|
Methylphenidate Sandoz |
18 mg |
Prolonged-release tablet |
Oral use |
|||||
Finland |
|
|
Methylphenidate Sandoz |
36 mg |
Prolonged-release tablet |
Oral use |
|||||
Finland |
|
|
Methylphenidate Sandoz |
54 mg |
Prolonged-release tablet |
Oral use |
|||||
France |
|
|
Méthylphénidate Sandoz LP 18 mg, comprimé à liberation prolongée |
18 mg |
Prolonged-release tablet |
Oral use |
|||||
France |
|
|
Méthylphénidate Sandoz LP 36 mg, comprimé à libération prolongée |
36 mg |
Prolonged-release tablet |
Oral use |
|||||
France |
|
|
Méthylphénidate Sandoz LP 54 mg, comprimé à librétaion prolongée |
54 mg |
Prolonged-release tablet |
Oral use |
|||||
Germany |
|
|
Methylphenidathydrochlorid - 1 A Pharma 18 mg Retardtabletten |
18 mg |
Prolonged-release tablet |
Oral use |
|||||
Germany |
|
|
Methylphenidathydrochlorid - 1 A Pharma 36 mg Retardtabletten |
36 mg |
Prolonged-release tablet |
Oral use |
|||||
Germany |
|
|
Methylphenidathydrochlorid - 1 A Pharma 54 mg Retardtabletten |
54 mg |
Prolonged-release tablet |
Oral use |
|||||
Iceland |
|
|
Methylphenidate Sandoz, 18 mg, forðatöflur |
18 mg |
Prolonged-release tablet |
Oral use |
|||||
Iceland |
|
|
Methylphenidate Sandoz, 36 mg, forðatöflur |
36 mg |
Prolonged-release tablet |
Oral use |
|||||
Iceland |
|
|
Methylphenidate Sandoz, 54 mg, forðatöflur |
54 mg |
Prolonged-release tablet |
Oral use |
|||||
Luxembourg |
|
|
Methylfenidaat Sandoz 18 mg comprimé à libération prolongée |
18 mg |
Prolonged-release tablet |
Oral use |
|||||
Luxembourg |
|
|
Methylfenidaat Sandoz 36 mg comprimé à libération prolongée |
36 mg |
Prolonged-release tablet |
Oral use |
|||||
Luxembourg |
|
|
Methylfenidaat Sandoz 54 mg comprimé à libération prolongée |
54 mg |
Prolonged-release tablet |
Oral use |
|||||
Malta |
|
|
Matoride XL 18 mg Prolonged-release Tablets |
18 mg |
Prolonged-release tablet |
Oral use |
|||||
Malta |
|
|
Matoride XL 36 mg Prolonged-release Tablets |
36 mg |
Prolonged-release tablet |
Oral use |
|||||
Malta |
|
|
Matoride XL 54 mg Prolonged-release Tablets |
54 mg |
Prolonged-release tablet |
Oral use |
|||||
Norway |
|
|
Methylphenidate Sandoz 18 mg depottabletter |
18 mg |
Prolonged-release tablet |
Oral use |
|||||
Norway |
|
|
Methylphenidate Sandoz 36 mg depottabletter |
36 mg |
Prolonged-release tablet |
Oral use |
|||||
Norway |
|
|
Methylphenidate Sandoz 54 mg depottabletter |
54 mg |
Prolonged-release tablet |
Oral use |
|||||
Poland |
|
|
Difumenil |
18 mg |
Prolonged-release tablet |
Oral use |
|||||
Poland |
|
|
Difumenil |
36 mg |
Prolonged-release tablet |
Oral use |
|||||
Poland |
|
|
Difumenil |
54 mg |
Prolonged-release tablet |
Oral use |
|||||
Portugal |
|
|
Metilfenidato Sandoz |
18 mg |
Prolonged-release tablet |
Oral use |
|||||
Portugal |
|
|
Metilfenidato Sandoz |
36 mg |
Prolonged-release tablet |
Oral use |
|||||
Portugal |
|
|
Metilfenidato Sandoz |
54 mg |
Prolonged-release tablet |
Oral use |
|||||
Spain |
|
|
Metilfenidato Sandoz 18 mg comprimidos de liberación prolongada EFG |
18 mg |
Prolonged-release tablet |
Oral use |
|||||
Spain |
|
|
Metilfenidato Sandoz 36 mg comprimidos de liberación prolongada EFG |
36 mg |
Prolonged-release tablet |
Oral use |
|||||
Spain |
|
|
Metilfenidato Sandoz 54 mg comprimidos de liberación prolongada EFG |
54 mg |
Prolonged-release tablet |
Oral use |
|||||
Sweden |
|
|
Methylphenidate Sandoz |
18 mg |
Prolonged-release tablet |
Oral use |
|||||
Sweden |
|
|
Methylphenidate Sandoz |
36 mg |
Prolonged-release tablet |
Oral use |
|||||
Sweden |
|
|
Methylphenidate Sandoz |
54 mg |
Prolonged-release tablet |
Oral use |
|||||
The Netherlands |
|
|
Methylfenidaat HCl Sandoz retard 18 mg, tabletten met verlengde afgifte |
18 mg |
Prolonged-release tablet |
Oral use |
|||||
The Netherlands |
|
|
Methylfenidaat HCl Sandoz retard 36 mg, tabletten met verlengde afgifte |
36 mg |
Prolonged-release tablet |
Oral use |
|||||
The Netherlands |
|
|
Methylfenidaat HCl Sandoz retard 54 mg, tabletten met verlengde afgifte |
54 mg |
Prolonged-release tablet |
Oral use |
|||||
United Kingdom |
|
|
Matoride XL 18 mg Prolonged-release Tablets |
18 mg |
Prolonged-release tablet |
Oral use |
|||||
United Kingdom |
|
|
Matoride XL 36 mg Prolonged-release Tablets |
36 mg |
Prolonged-release tablet |
Oral use |
|||||
United Kingdom |
|
|
Matoride XL 54 mg Prolonged-release Tablets |
54 mg |
Prolonged-release tablet |
Oral use |
ANNEX IV
LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE VETERINARY MEDICINAL PRODUCTS, ANIMAL SPECIES, APPLICANTS/MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
Member State EU/EEA |
Applicant/marketing authorisation holder |
Name |
INN |
Strength |
Pharmaceutical form |
Animal species |
|||||
Austria |
|
Hexadreson 2 mg/ml Injektionslösung für Pferde, Rinder, Schweine, Hunde |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Austria |
|
Rapidexon 2 mg/ml Injektionslösung für Pferde, Rinder, Schweine, Katzen und Hunde |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Belgium |
|
RAPIDEXON 2 MG/ML SOLUTION INJECTABLE |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Belgium |
|
DEXA-JECT 2 MG/ML oplossing voor injectie voor runderen, paarden, varkens, honden en katten |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Cyprus |
|
DEXADRESON INJECTION 2 MG/ML |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Czech republic |
|
Dexadreson, 2 mg/ml Injekční roztok |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Czech republic |
|
RAPIDEXON 2 mg/ml injekční roztok |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Denmark |
|
Dexadreson Vet |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses |
|||||
Denmark |
|
Dexaject |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Denmark |
|
Rapidexon |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Finland |
|
Rapidexon vet |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
France |
|
Dexadreson |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, goat, pigs, dogs and cats. |
|||||
France |
|
Rapidexon 2 mg/ml solution injectable |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
France |
|
Cortadex 2 mg/ml solution injectable pour bovins, porcins, chiens et chats |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, pigs, dogs and cats |
|||||
France |
|
Dexa-ject 2 mg/ml solution injectable pour bovins, chevaux, porcins, chiens et chats |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Germany |
|
Hexadreson |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Germany |
|
Rapidexon Albrecht 2 mg/ml |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Germany |
|
Dexa-ject 2 mg/ml |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Greece |
|
DEXADRESON |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Greece |
|
RAPIDEXON |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Hungary |
|
Dexadreson injekció A.U.V. |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Hungary |
|
Dexa-ject 2 mg/ml injekció szarvasmarhák, lovak, sertések, kutyák és macskák részére A.U.V. |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Hungary |
|
Rapidexon 2 mg/ml injekció A.U.V. |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Iceland |
|
Dexaject |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Ireland |
|
Dexadresson 2 mg/ml solution for injection |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Ireland |
|
Rapidexon 2 mg/ml solution for injection |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Ireland |
|
Dexa-ject 2 mg/ml solution for injection for cattle, horses, pigs, dogs and cats |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Italy |
|
Dexadreson |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, goat, pigs, dogs and cats. |
|||||
Latvia |
|
Dexacortin |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, pigs, dogs and cats |
|||||
Lithuania |
|
DEXACORTIN 2 mg/ml solution for injection for cattle, swine, dogs and cats |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, pigs, dogs and cats |
|||||
Lithuania |
|
RAPIDEXON 2 mg/ml, solution for injection |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Lithuania |
|
DEXA-JECT 2 mg/ml solution for injection for cattle, horse, pigs, dogs and cats |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
The Netherlands |
|
Dexadreson |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle |
|||||
The Netherlands |
|
Rapidexon |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle |
|||||
The Netherlands |
|
Rapidexon |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
The Netherlands |
|
Dexa-ject |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Norway |
|
Dexadreson vet. |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Poland |
|
DEXACORTIN 2 mg/ml roztwór do wstrzykiwań dla bydła, świń, psów i kotów |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, pigs, dogs and cats. |
|||||
Poland |
|
RAPIDEXON 2 mg/ml roztwór do wstrzykiwań |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Poland |
|
Dexa-ject 2 mg/ml roztwór do wstrzykiwań dla bydła, koni, świń, psów i kotów |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Portugal |
|
Rapidexon 2 mg/ml, solução injectável |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Portugal |
|
Dexacortin 2 mg/ml solução injectável para bovinos, suínos, cães e gatos |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, pigs, dogs and cats |
|||||
Romania |
|
DEXADRESON |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, goat, pigs, dogs and cats |
|||||
Slovakia |
|
Dexadreson 2 mg/ml injekčný roztok |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Slovakia |
|
Rapidexon 2 mg/ml injekčný roztok |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Slovenia |
|
RAPIDEXON 2 mg/ml raztopina za injiciranje |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Slovenia |
|
DEXACORTIN 2 mg/ml, raztopina za injiciranje za govedo, prašiče, pse in mačke |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, pigs, dogs and cats |
|||||
Spain |
|
Rapidexon 2 mg/ml solución inyectable |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Spain |
|
Dexavex |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Spain |
|
Dexa-ject 2 mg/ml |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
Sweden |
|
Dexadreson vet. |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
United Kingdom |
|
Dexadreson 2 mg/ml Solution for Injection |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
United Kingdom |
|
Dexa-ject 2 mg/ml Solution for Injection for Cattle, Horses, Pigs, Dogs and Cats |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
|||||
United Kingdom |
|
Rapidexon 2 mg/ml Solution for Injection |
Dexamethasone |
2 mg/ml |
Solution for injection |
Cattle, horses, pigs, dogs and cats |
ANNEX V
LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE VETERINARY MEDICINAL PRODUCT, ANIMAL SPECIES, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
Member State EU/EEA |
Marketing authorisation holder |
Name |
INN |
Strength |
Pharmaceutical form |
Animal species |
Route of administration |
|||||||
Austria |
|
Micotil 300 mg/ml - Injektionslösung für Rinder |
Tilmicosin |
300 mg/ml |
Solution for injection |
Cattle |
Subcutaneous injection |
|||||||
Belgium |
|
Micotil 300 mg/ml |
Tilmicosin |
300 mg/ml |
Solution for injection |
Cattle, sheep |
Subcutaneous injection |
|||||||
Czech Republic |
|
Micotil 300 mg/ml injekční roztok pro skot (telata, mladý skot) |
Tilmicosin |
300 mg/ml |
Solution for injection |
Cattle |
Subcutaneous injection |
|||||||
Germany |
|
Micotil 300 |
Tilmicosin |
300 mg/ml |
Solution for injection |
Cattle |
Subcutaneous injection |
|||||||
France |
|
MICOTIL 300 |
Tilmicosin |
300 mg/ml |
Solution for injection |
Cattle |
Subcutaneous injection |
|||||||
Greece |
|
MICOTIL 300 |
Tilmicosin |
300 mg/ml |
Solution for injection |
Cattle, sheep |
Subcutaneous injection |
|||||||
Spain |
|
Micotil 300 |
Tilmicosin |
300 mg/ml |
Solution for injection |
Cattle |
Subcutaneous injection |
|||||||
Hungary |
|
Micotil 300 injekció |
Tilmicosin |
300 mg/ml |
Solution for injection |
Cattle |
Subcutaneous injection |
|||||||
Ireland |
|
Micotil 300 mg/ml Solution for Injection |
Tilmicosin |
300 mg/ml |
Solution for injection |
Cattle, sheep |
Subcutaneous injection |
|||||||
Italy |
|
Micotil 300 |
Tilmicosin |
300 mg/ml |
Solution for injection |
Cattle, sheep rabbit |
Subcutaneous injection |
|||||||
The Netherlands |
|
MICOTIL 300 INJECTIE |
Tilmicosin |
300 mg/ml |
Solution for injection |
Cattle, sheep |
Subcutaneous injection |
|||||||
Portugal |
|
Micotil 300 mg/ml solução injectável |
Tilmicosin |
300 mg/ml |
Solution for injection |
Cattle |
Subcutaneous injection |
|||||||
United Kingdom |
|
Micotil 300 mg/ml Solution for Injection |
Tilmicosin |
300 mg/ml |
Solution for injection |
Cattle, sheep |
Subcutaneous injection |
ANNEX VI
LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTES OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
Member State EU/EEA |
Marketing authorisation holder |
Invented Name |
Strength |
Pharmaceutical form |
Route of administration |
Content (concentration) |
|||||
Austria |
|
Sandimmun 50 mg – Konzentrat zur Infusionsbereitung |
50 mg/ml |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
|||||
Belgium |
|
SANDIMMUN |
50 mg/ml |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
|||||
Czech Republic |
|
Sandimmun |
50 mg/ml |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
|||||
Denmark |
|
Sandimmun |
50 mg/ml |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
|||||
Finland |
|
Sandimmun |
50 mg/ml |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
|||||
France |
|
SANDIMMUN |
25 mg |
Capsule, soft |
Oral use |
|
|||||
France |
|
SANDIMMUN |
50 mg |
Capsule, soft |
Oral use |
|
|||||
France |
|
SANDIMMUN |
100 mg |
Capsule, soft |
Oral use |
|
|||||
France |
|
SANDIMMUN |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
France |
|
SANDIMMUN |
50 mg/ml |
Solution for infusion |
Intravenous use |
50 mg/ml |
|||||
Germany |
|
Sandimmun 25 mg Weichkapseln |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Germany |
|
Sandimmun 100 mg Weichkapseln |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Germany |
|
Sandimmun 100 mg/ml Lösung zum Einnehmen |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Germany |
|
Sandimmun 50 mg/ml Konzentrat zur Herstellung einer Infusionslösung |
50 mg/ml |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
|||||
Germany |
|
Immunosporin 25 mg Weichkapseln |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Germany |
|
Immunosporin 50 mg Weichkapseln |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Germany |
|
Immunosporin 100 mg Weichkapseln |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Greece |
|
SANDIMMUN |
250 mg/5 ml amp |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
|||||
Greece |
|
SANDIMMUN |
50 mg/ml amp |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
|||||
Hungary |
|
Sandimmun 50 mg/ml koncentrátum oldatos infúzióhoz |
50 mg/ml |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
|||||
Iceland |
|
Sandimmun |
50 mg/ml |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
|||||
Ireland |
|
Sandimmun |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Ireland |
|
Sandimmun |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Ireland |
|
Sandimmun |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Ireland |
|
Sandimmun |
100 mg/ml |
Oral Solution |
Oral use |
100 mg/ml |
|||||
Ireland |
|
Sandimmun |
50 mg/1 ml |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
|||||
Italy |
|
SANDIMMUN |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Italy |
|
SANDIMMUN |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Italy |
|
SANDIMMUN |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Italy |
|
SANDIMMUN |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Italy |
|
SANDIMMUN |
50 mg/ml |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
|||||
Luxembourg |
|
Sandimmun 25 mg Weichkapseln |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Luxembourg |
|
Sandimmun 100 mg Weichkapseln |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Luxembourg |
|
Sandimmun 100 mg/ml Lösung zum Einnehmen |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Luxembourg |
|
Sandimmun 50 mg/ml Konzentrat zur Herstellung einer Infusionslösung |
50 mg/ml |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
|||||
Netherlands |
|
Sandimmune, concentraat voor oplossing voor intraveneuze infusie 50 mg/ml |
50 mg/ml |
Concentrate for solution for intravenous infusion |
Intravenous use |
50 mg/ml |
|||||
Norway |
|
Sandimmun |
50 mg/ml |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
|||||
Poland |
|
Sandimmun |
50 mg/ml |
Concentrate for solution for infusion |
Intravenous |
50 mg/ml |
|||||
Portugal |
|
Sandimmun |
50 mg/ml |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
|||||
Slovak Republic |
|
Sandimmun 50 mg/ml |
50 mg/ml |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
|||||
Slovenia |
|
Sandimmun 50 mg/ml koncentrat za raztopino za infundiranje |
50 mg/ml |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
|||||
Spain |
|
Sandimmun 50 mg/ml concentrado para solución para perfusión |
50 mg/ml |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
|||||
Spain |
|
Sandimmun 250 mg/5 ml concentrado para solución para perfusión |
250 mg/5 ml |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
|||||
Sweden |
|
Sandimmun |
50 mg/ml |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
|||||
United Kingdom |
|
SANDIMMUN Soft Gelatin Capsules 25 mg |
25 mg |
Capsule, soft |
Oral use |
|
|||||
United Kingdom |
|
SANDIMMUN Soft Gelatin Capsules 50 mg |
50 mg |
Capsule, soft |
Oral use |
|
|||||
United Kingdom |
|
SANDIMMUN Soft Gelatin Capsules 100 mg |
100 mg |
Capsule, soft |
Oral use |
|
|||||
United Kingdom |
|
SANDIMMUN Oral Solution |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
United Kingdom |
|
SANDIMMUN Concentrate for Solution for Infusion 50 mg/ml |
50 mg/ml |
Concentrate for solution for infusion |
Intravenous use |
50 mg/ml |
ANNEX VII
LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
Member State EU/EEA |
Marketing authorisation holder |
Invented Name |
Strength |
Pharmaceutical form |
Route of administration |
Content (concentration) |
|||||
Austria |
|
Sandimmun - Neoral 10 mg Kapseln |
10 mg |
Capsule, soft |
Oral use |
|
|||||
Austria |
|
Sandimmun - Neoral 25 mg Kapseln |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Austria |
|
Sandimmun - Neoral 50 mg Kapseln |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Austria |
|
Sandimmun - Neoral 100 mg Kapseln |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Austria |
|
Sandimmun - Neoral 100 mg/ml - Trinklösung |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Belgium |
|
Neoral - Sandimmun 10 mg |
10 mg |
Capsule |
Oral use |
|
|||||
Belgium |
|
Neoral-Sandimmun 100 mg |
100 mg |
Capsule |
Oral use |
|
|||||
Belgium |
|
Neoral - Sandimmun 25 mg |
25 mg |
Capsule |
Oral use |
|
|||||
Belgium |
|
Neoral - Sandimmun 50 mg |
50 mg |
Capsule |
Oral use |
|
|||||
Belgium |
|
Neoral-Sandimmun 100 mg/ml |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Bulgaria |
|
Sandimmun Neoral 25 mg capsule |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Bulgaria |
|
Sandimmun Neoral 50 mg capsule |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Bulgaria |
|
Sandimmun Neoral 100 mg capsule |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Bulgaria |
|
Sandimmun Neoral 100 mg/ml oral solution |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml – 50 ml |
|||||
Cyprus |
|
Sandimmun Neoral 25 mg |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Cyprus |
|
Sandimmun Neoral 50 mg |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Cyprus |
|
Sandimmun Neoral 100 mg |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Cyprus |
|
Sandimmun Neoral Oral Solution 100 mg/ ml |
100 mg/ml |
Oral Solution |
Oral use |
100 mg/ml |
|||||
Czech Republic |
|
Sandimmun Neoral 25 mg |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Czech Republic |
|
Sandimmun Neoral 50 mg |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Czech Republic |
|
Sandimmun Neoral 100 mg |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Czech Republic |
|
Sandimmun Neoral 100 mg/ml |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Denmark |
|
Sandimmun Neoral |
10 mg |
Capsule, soft |
Oral use |
|
|||||
Denmark |
|
Sandimmun Neoral |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Denmark |
|
Sandimmun Neoral |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Denmark |
|
Sandimmun Neoral |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Denmark |
|
Sandimmun Neoral |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Estonia |
|
Sandimmun Neoral |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Estonia |
|
Sandimmun Neoral |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Estonia |
|
Sandimmun Neoral |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Finland |
|
Sandimmun Neoral |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Finland |
|
Sandimmun Neoral |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Finland |
|
Sandimmun Neoral |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Finland |
|
Sandimmun Neoral |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
France |
|
NEORAL |
10 mg |
Capsule, soft |
Oral use |
|
|||||
France |
|
NEORAL |
25 mg |
Capsule, soft |
Oral use |
|
|||||
France |
|
NEORAL |
50 mg |
Capsule, soft |
Oral use |
|
|||||
France |
|
NEORAL |
100 mg |
Capsule, soft |
Oral use |
|
|||||
France |
|
NEORAL |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Germany |
|
Sandimmun Optoral 10 mg Weichkapseln |
10 mg |
Capsule, soft |
Oral use |
|
|||||
Germany |
|
Sandimmun Optoral 25 mg Weichkapseln |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Germany |
|
Sandimmun Optoral 50 mg Weichkapseln |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Germany |
|
Sandimmun Optoral 100 mg Weichkapseln |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Germany |
|
Sandimmun Optoral 100 mg/ml Lösung zum Einnehmen |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Greece |
|
SANDIMMUN NEORAL |
25 mg/cap |
Capsule, soft |
Oral use |
|
|||||
Greece |
|
SANDIMMUN NEORAL |
50 mg/cap |
Capsule, soft |
Oral use |
|
|||||
Greece |
|
SANDIMMUN NEORAL |
100 mg/cap |
Capsule, soft |
Oral use |
|
|||||
Greece |
|
SANDIMMUN NEORAL |
500 mg/5 ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Hungary |
|
Sandimmun Neoral 10 mg lágy kapszula |
10 mg |
Capsule, soft |
Oral use |
|
|||||
Hungary |
|
Sandimmun Neoral 25 mg lágy kapszula |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Hungary |
|
Sandimmun Neoral 50 mg lágy kapszula |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Hungary |
|
Sandimmun Neoral 100 mg lágy kapszula |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Hungary |
|
Sandimmun Neoral 100 mg/ml belsőleges oldat |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Iceland |
|
Sandimmun Neoral |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Iceland |
|
Sandimmun Neoral |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Iceland |
|
Sandimmun Neoral |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Iceland |
|
Sandimmun Neoral |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Ireland |
|
Neoral |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Ireland |
|
Neoral |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Ireland |
|
Neoral |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Ireland |
|
Neoral |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Italy |
|
Sandimmun Neoral |
10 mg |
Capsule, soft |
Oral use |
|
|||||
Italy |
|
Sandimmun Neoral |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Italy |
|
Sandimmun Neoral |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Italy |
|
Sandimmun Neoral |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Italy |
|
Sandimmun Neoral |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Latvia |
|
Sandimmun Neoral 25 mg mīkstās kapsulas |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Latvia |
|
Sandimmun Neoral 50 mg mīkstās kapsulas |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Latvia |
|
Sandimmun Neoral 100 mg mīkstās kapsulas |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Lithuania |
|
Sandimmun Neoral |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Lithuania |
|
Sandimmun Neoral |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Lithuania |
|
Sandimmun Neoral |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Luxembourg |
|
Sandimmun Optoral 10 mg Weichkapseln |
10 mg |
Capsule, soft |
Oral use |
|
|||||
Luxembourg |
|
Sandimmun Optoral 25 mg Weichkapseln |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Luxembourg |
|
Sandimmun Optoral 50 mg Weichkapseln |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Luxembourg |
|
Sandimmun Optoral 100 mg Weichkapseln |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Luxembourg |
|
Sandimmun Optoral 100 mg/ml Lösung zum Einnehmen |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Malta |
|
Sandimmun Neoral |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Malta |
|
Sandimmun Neoral |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Malta |
|
Sandimmun Neoral |
100 mg/ml |
Oral Solution |
Oral use |
100 mg/ml |
|||||
Netherlands |
|
Neoral 25 mg, capsules |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Netherlands |
|
Neoral 100 mg, capsules |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Netherlands |
|
Neoral 100 mg/ml, drank |
100 mg/ml |
Oral Solution |
Oral use |
100 mg/ml |
|||||
Norway |
|
Sandimmun Neoral |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Norway |
|
Sandimmun Neoral |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Norway |
|
Sandimmun Neoral |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Norway |
|
Sandimmun Neoral |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Poland |
|
Sandimmun Neoral |
10 mg |
Capsule, soft |
Oral use |
|
|||||
Poland |
|
Sandimmun Neoral |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Poland |
|
Sandimmun Neoral |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Poland |
|
Sandimmun Neoral |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Poland |
|
Sandimmun Neoral |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Portugal |
|
Sandimmun Neoral |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Portugal |
|
Sandimmun Neoral |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Portugal |
|
Sandimmun Neoral |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Portugal |
|
Sandimmun Neoral |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Romania |
|
SANDIMMUN NEORAL capsule moi, 25 mg |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Romania |
|
SANDIMMUN NEORAL,capsule moi, 50 mg |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Romania |
|
SANDIMMUN NEORAL, solutie orala, 100 mg/ml |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Slovak Republic |
|
Sandimmun Neoral 25 mg |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Slovak Republic |
|
Sandimmun Neoral 50 mg |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Slovak Republic |
|
Sandimmun Neoral 100 mg |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Slovak Republic |
|
Sandimmun Neoral 100 mg/ml |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Slovenia |
|
Sandimmun Neoral 25 mg mehke kapsule |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Slovenia |
|
Sandimmun Neoral 50 mg mehke kapsule |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Slovenia |
|
Sandimmun Neoral 100 mg mehke kapsule |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Slovenia |
|
Sandimmun Neoral 100 mg/ml peroralna raztopina |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Spain |
|
Sandimmun Neoral 25 mg cápsulas blandas |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Spain |
|
Sandimmun Neoral 50 mg cápsulas blandas |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Spain |
|
Sandimmun Neoral 100 mg cápsulas blandas |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Spain |
|
Sandimmun Neoral 100 mg/ml solución oral |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
Sweden |
|
Sandimmun Neoral |
10 mg |
Capsule, soft |
Oral use |
|
|||||
Sweden |
|
Sandimmun Neoral |
25 mg |
Capsule, soft |
Oral use |
|
|||||
Sweden |
|
Sandimmun Neoral |
50 mg |
Capsule, soft |
Oral use |
|
|||||
Sweden |
|
Sandimmun Neoral |
100 mg |
Capsule, soft |
Oral use |
|
|||||
Sweden |
|
Sandimmun Neoral |
100 mg/ml |
Oral solution |
Oral use |
100 mg/ml |
|||||
United Kingdom |
|
Neoral Soft Gelatin Capsules 10 mg |
10 mg |
Capsule, soft |
Oral use |
|
|||||
United Kingdom |
|
Neoral Soft Gelatin Capsules 25 mg |
25 mg |
Capsule, soft |
Oral use |
|
|||||
United Kingdom |
|
Neoral Soft Gelatin Capsules 50 mg |
50 mg |
Capsule, soft |
Oral use |
|
|||||
United Kingdom |
|
Neoral Soft Gelatin Capsules 100 mg |
100 mg |
Capsule, soft |
Oral use |
|
|||||
United Kingdom |
|
Neoral Oral solution |
100 mg/ml |
Oral Solution |
Oral use |
100 mg/ml |
ANNEX VIII
LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTES OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
Member State (in EEA) |
Marketing Authorisation Holder |
Invented name |
Strength |
Pharmaceutical Form |
Route of administration |
|||||
Belgium |
|
Nizoral 200 mg tabletten |
200 mg |
Tablet |
Oral use |
|||||
Bulgaria |
|
NIZORAL |
200 mg |
Tablet |
Oral use |
|||||
Cyprus |
|
KETOZAL TABLETS 200 mg |
200 mg |
Tablet |
Oral use |
|||||
Cyprus |
|
KETROZOL TABLETS 200 mg |
200 mg |
Tablet |
Oral use |
|||||
Cyprus |
|
NIZORAL TABLETS 200 mg |
200 mg |
Tablet |
Oral use |
|||||
Cyprus |
|
TINUVIN TABLETS 200 mg |
200 mg |
Tablet |
Oral use |
|||||
Cyprus |
|
VAFLUSON TABLETS 200 mg |
200 mg |
Tablet |
Oral use |
|||||
Czech Republic |
|
NIZORAL |
200 mg |
Tablet |
Oral use |
|||||
Estonia |
|
NIZORAL |
200 mg |
Tablet |
Oral use |
|||||
Finland |
|
NIZORAL |
200 mg |
Tablet |
Oral use |
|||||
France |
|
NIZORAL 200 mg, comprimé |
200 mg |
Tablet |
Oral use |
|||||
Greece |
|
MYCOFEBRIN |
200 mg |
Tablet |
Oral use |
|||||
Greece |
|
AQUARIUS |
200 mg |
Tablet |
Oral use |
|||||
Greece |
|
ILGEM |
200 mg |
Tablet |
Oral use |
|||||
Greece |
|
SOSTATIN |
200 mg |
Tablet |
Oral use |
|||||
Greece |
|
EBERSEPT |
200 mg |
Tablet |
Oral use |
|||||
Hungary |
|
NIZORAL 200 mg tabletta |
200 mg |
Tablet |
Oral use |
|||||
Iceland |
|
Fungoral |
200 mg |
Tablet |
Oral use |
|||||
Latvia |
|
Nizoral 200 mg tablets |
200 mg |
Tablet |
Oral use |
|||||
Lithuania |
|
Nizoral |
200 mg |
Tablet |
Oral use |
|||||
Luxembourg |
|
Nizoral 200 mg comprimés |
200 mg |
Tablet |
Oral use |
|||||
Norway |
|
Fungoral |
200 mg |
Tablet |
Oral use |
|||||
Poland |
|
Ketokonazol |
200 mg |
Tablet |
Oral use |
|||||
Portugal |
|
Nizale |
200 mg |
Tablet |
Oral use |
|||||
Romania |
|
KETOCONAZOL ARENA 200 mg |
200 mg |
Tablet |
Oral use |
|||||
Romania |
|
NIZORAL 200 mg |
200 mg |
Tablet |
Oral use |
|||||
Romania |
|
KETOCONAZOL 200 mg |
200 mg |
Tablet |
Oral use |
|||||
Romania |
|
KETOCONAZOL 200 mg |
200 mg |
Tablet |
Oral use |
|||||
Romania |
|
KETOSTIN 200 mg |
200 mg |
Tablet |
Oral use |
|||||
Slovak Republic |
|
NIZORAL |
200 mg |
Tablet |
Oral use |
|||||
Spain |
|
FUNGO ZEUS 200 mg comprimidos |
200 mg |
Tablet |
Oral use |
|||||
Spain |
|
FUNGAREST comprimidos |
200 mg |
Tablet |
Oral use |
|||||
Spain |
|
Ketoconazol ratiopharm 200 mg comprimidos |
200 mg |
Tablet |
Oral use |
|||||
Sweden |
|
Fungoral® |
200 mg |
Tablet |
Oral use |
|||||
The Netherlands |
|
Nizoral tabletten 200 mg |
200 mg |
Tablet |
Oral use |
|||||
United Kingdom |
|
Nizoral 200 mg tablets |
200 mg |
Tablet |
Oral use |